资讯

Walmart's AI bet has been accompanied by a change in the business processes needed to deal with AI. Glick said Walmart has 14 ...
Regulators in the EU, China, and Japan have started reviews of GSK's depemokimab, aiming to become the first drug for severe asthma that can be given just twice a year. The EMA and counterparts in ...